Cardinal Health, a leading global healthcare services and products company, is headquartered in the United States. Founded in 1971, the company has established itself as a key player in the healthcare industry, primarily focusing on pharmaceutical distribution and medical products. With a strong presence across North America and significant operations in Europe and Asia, Cardinal Health serves a diverse range of healthcare providers, including hospitals, pharmacies, and clinics. The company offers a comprehensive portfolio of services, including supply chain management, medication management, and clinical solutions, which are designed to enhance patient care and operational efficiency. Notably, Cardinal Health is recognised for its commitment to innovation and quality, positioning itself as a trusted partner in the healthcare ecosystem. With a robust market position, Cardinal Health continues to achieve significant milestones, reinforcing its reputation as a vital contributor to the healthcare landscape.
How does Cardinal Health's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Cardinal Health's score of 77 is higher than 99% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2023, Cardinal Health reported total greenhouse gas emissions of approximately 38,316,000 kg CO2e, with emissions distributed across various scopes: 163,044,000 kg CO2e for Scope 1, 220,684,000 kg CO2e for Scope 2 (market-based), and 21,363,272,000 kg CO2e for Scope 3. This represents a significant increase in emissions compared to previous years, reflecting the company's growth and operational expansion. Cardinal Health has set ambitious climate commitments, aiming to reduce absolute Scope 1 and 2 greenhouse gas emissions by 50% by fiscal year 2030, using fiscal year 2019 as the baseline. This target aligns with science-based targets and includes a commitment that 75% of its suppliers by spend will also have science-based targets by fiscal year 2028. In 2022, the company reported Scope 1 emissions of 167,115,000 kg CO2e and Scope 2 emissions of 223,745,000 kg CO2e (market-based), while in 2021, Scope 1 emissions were 156,100,000 kg CO2e and Scope 2 emissions were 234,339,000 kg CO2e. The trend indicates a focus on reducing emissions, particularly in the context of their operational footprint and supply chain management. Overall, Cardinal Health's climate strategy reflects a commitment to sustainability within the healthcare sector, addressing both direct and indirect emissions through targeted reduction initiatives.
Access structured emissions data, company-specific emission factors, and source documents
2018 | 2019 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|---|
Scope 1 | 177,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Scope 2 | 335,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Scope 3 | 23,000,000 | 00,000,000 | - | 0,000,000 | 00,000,000,000 | 00,000,000,000 |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Cardinal Health is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.